national hansen’s disease program national hansen’s disease program

52
NATIONAL HANSEN’S DISEASE PROGRAM

Upload: monserrat-fawley

Post on 14-Jan-2016

248 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

NATIONALHANSEN’S DISEASE

PROGRAM

NATIONALHANSEN’S DISEASE

PROGRAM

Page 2: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

REACTIONS INHANSEN’S DISEASE

REACTIONS INHANSEN’S DISEASE

Page 3: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

REACTIONS - What are they?REACTIONS - What are they?

• Increased immune response

• Not treatment failure, drug toxicity or drug allergy

• Increased immune response

• Not treatment failure, drug toxicity or drug allergy

Page 4: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

TERMINOLOGYTERMINOLOGY

•Reversal Reaction (Type 1)Upgrading reaction in BT, BB, BL

•Reversal Reaction (Type 1)Upgrading reaction in BT, BB, BL

•Erythema Nodosum Leprosum (Type 2)Immune complex disorder in BL and LL

•Erythema Nodosum Leprosum (Type 2)Immune complex disorder in BL and LL

•Lucio PhenomenonReaction in Lucio Leprosy

•Lucio PhenomenonReaction in Lucio Leprosy

Page 5: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

NEURITISNEURITIS

• Tender or painful nerves with or without other symptoms of reaction

• Silent neuritis – deterioration of nerve function without other symptoms of reaction

• Tender or painful nerves with or without other symptoms of reaction

• Silent neuritis – deterioration of nerve function without other symptoms of reaction

Page 6: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

REVERSAL REACTION REVERSAL REACTION

• Coombs and Gell type IV hypersensitivity

• Shift of cell mediated immunity toward tuberculoid disease

• Occurs in BT, BB and BL disease

• Coombs and Gell type IV hypersensitivity

• Shift of cell mediated immunity toward tuberculoid disease

• Occurs in BT, BB and BL disease

Page 7: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

The Hansen’s Disease SpectrumThe Hansen’s Disease Spectrum

LEPROMATOUSLEPROMATOUS

MANYMANYBACTERIABACTERIA

ANTIBODYANTIBODYLEVELSLEVELS

HIGHHIGH

LOW RESISTANCELOW RESISTANCETO M. LEPRAETO M. LEPRAE

TT BT BB BL LLTT BT BB BL LL

HIGH RESISTANCEHIGH RESISTANCETO M. LEPRAETO M. LEPRAE

LOWLOWANTIBODYANTIBODY

LEVELSLEVELS

BACTERIABACTERIAFEWFEW

TUBERCULOIDTUBERCULOID

CMICMI BIBI

ENLENL

ANTIBODY

ANTIBODY

LEVEL

LEVEL

Reversal Reaction

Reversal Reaction

Page 8: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 9: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 10: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

ERYTHEMA NODOSUM LEPROSUMERYTHEMA NODOSUM LEPROSUM

• Immune complex disorder

• Coombs and Gell type III hypersensitivity

• TNF levels increase during ENL

• Neutrophil infiltration

• Occurs in BL and LL disease

• Immune complex disorder

• Coombs and Gell type III hypersensitivity

• TNF levels increase during ENL

• Neutrophil infiltration

• Occurs in BL and LL disease

Page 11: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

The Hansen’s Disease SpectrumThe Hansen’s Disease Spectrum

LEPROMATOUSLEPROMATOUS

MANYMANYBACTERIABACTERIA

ANTIBODYANTIBODYLEVELSLEVELS

HIGHHIGH

LOW RESISTANCELOW RESISTANCETO M. LEPRAETO M. LEPRAE

TT BT BB BL LLTT BT BB BL LL

HIGH RESISTANCEHIGH RESISTANCETO M. LEPRAETO M. LEPRAE

LOWLOWANTIBODYANTIBODY

LEVELSLEVELS

BACTERIABACTERIAFEWFEW

TUBERCULOIDTUBERCULOID

CMICMI BIBI

ENLENL

ANTIBODY

ANTIBODY

LEVEL

LEVEL

Reversal Reaction

Reversal Reaction

Page 12: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 13: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 14: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

The Hansen’s Disease SpectrumThe Hansen’s Disease Spectrum

LEPROMATOUSLEPROMATOUS

MANYMANYBACTERIABACTERIA

ANTIBODYANTIBODYLEVELSLEVELS

HIGHHIGH

LOW RESISTANCELOW RESISTANCETO M. LEPRAETO M. LEPRAE

TT BT BB BL LLTT BT BB BL LL

HIGH RESISTANCEHIGH RESISTANCETO M. LEPRAETO M. LEPRAE

LOWLOWANTIBODYANTIBODY

LEVELSLEVELS

BACTERIABACTERIAFEWFEW

TUBERCULOIDTUBERCULOID

CMICMI BIBI

ENLENL

ANTIBODY

ANTIBODY

LEVEL

LEVEL

Reversal Reaction

Reversal Reaction

Page 15: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

PRECIPITATING FACTORSIN REACTIONS

PRECIPITATING FACTORSIN REACTIONS

• Physical or mental stress

• Pregnancy

• Surgical procedures

• Injuries

• Intercurrent infections

• Antibacterial treatment of HD

• Physical or mental stress

• Pregnancy

• Surgical procedures

• Injuries

• Intercurrent infections

• Antibacterial treatment of HD

Page 16: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

DIAGNOSIS OF REACTIONDIAGNOSIS OF REACTION

• Worsening of existing skin lesions with increased edema erythema

• New erythematous skin lesions

• Painful or tender nerves

• Pain and/or swelling of hands and feet

• Worsening of existing skin lesions with increased edema erythema

• New erythematous skin lesions

• Painful or tender nerves

• Pain and/or swelling of hands and feet

Page 17: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

REVERSAL REACTIONREVERSAL REACTION

• Usually occurs within first six months of treatment

• Nerve damage may occur rapidly

• Reversal reaction with acute neuritis is a medical emergency

• Usually occurs within first six months of treatment

• Nerve damage may occur rapidly

• Reversal reaction with acute neuritis is a medical emergency

Page 18: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 19: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 20: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 21: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 22: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 23: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 24: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 25: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 26: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 27: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 28: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 29: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 30: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 31: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

EDEMA DURING REACTIONSEDEMA DURING REACTIONS

• Edema of hands and feet is a common symptom

• Swelling of hands can cause permanent stiffness

• Edema of hands and feet should always be considered a symptom of severe reaction

• Edema of hands and feet is a common symptom

• Swelling of hands can cause permanent stiffness

• Edema of hands and feet should always be considered a symptom of severe reaction

Page 32: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 33: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 34: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 35: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 36: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

ENL ENL

• Usually 1 – 3 years after beginning treatment

• Involves skin, nerves, eyes and other organs

• May present as a febrile illness

• Nerve damage usually slow

• Usually 1 – 3 years after beginning treatment

• Involves skin, nerves, eyes and other organs

• May present as a febrile illness

• Nerve damage usually slow

Page 37: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 38: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 39: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 40: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 41: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 42: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 43: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 44: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM
Page 45: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

CLINICAL FEATURES OF REACTIONCLINICAL FEATURES OF REACTION

Reversal ReactionReversal Reaction -- Assymetric skin andAssymetric skin andnerve involvementnerve involvement

ENLENL -- Diffuse skin and nerveDiffuse skin and nerveinvolvementinvolvement

Reversal ReactionReversal Reaction -- Nerve pain and acuteNerve pain and acutenerve damage rapidnerve damage rapid

ENLENL -- Chronic nerve pain andChronic nerve pain andnerve damage slownerve damage slow

Reversal ReactionReversal Reaction -- Assymetric skin andAssymetric skin andnerve involvementnerve involvement

ENLENL -- Diffuse skin and nerveDiffuse skin and nerveinvolvementinvolvement

Reversal ReactionReversal Reaction -- Nerve pain and acuteNerve pain and acutenerve damage rapidnerve damage rapid

ENLENL -- Chronic nerve pain andChronic nerve pain andnerve damage slownerve damage slow

Page 46: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

CLINICAL FEATURES OF REACTIONCLINICAL FEATURES OF REACTION

REACTION:REACTION:REACTION:REACTION:

Reversal ReactionReversal Reaction -- BT, BB, BLBT, BB, BLENLENL -- BL and LLBL and LLReversal ReactionReversal Reaction -- BT, BB, BLBT, BB, BLENLENL -- BL and LLBL and LL

LESIONS IN REACTIONLESIONS IN REACTION::LESIONS IN REACTIONLESIONS IN REACTION::

Reversal ReactionReversal Reaction -- Usually appears in Usually appears in previously existing skinpreviously existing skinlesions.lesions.

ENLENL -- Appears in normal skinAppears in normal skin..

Reversal ReactionReversal Reaction -- Usually appears in Usually appears in previously existing skinpreviously existing skinlesions.lesions.

ENLENL -- Appears in normal skinAppears in normal skin..

Page 47: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

REACTIONSREACTIONS

MILDMILD SEVERESEVEREMILDMILD SEVERESEVERE

Painful/tender nervesPainful/tender nerves X X

Swelling/pain of the faceSwelling/pain of the face X X

Edema of hands/feetEdema of hands/feet X X

Painless skin lesionsPainless skin lesions X X

Painful/tender nervesPainful/tender nerves X X

Swelling/pain of the faceSwelling/pain of the face X X

Edema of hands/feetEdema of hands/feet X X

Painless skin lesionsPainless skin lesions X X

Page 48: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

REVERSAL REACTION TREATMENTREVERSAL REACTION TREATMENT

MildMild•Symptomatic treatment•Symptomatic treatment

SevereSevere•Prednisone 40 - 80 mg single dose daily for 5 - 7 days; taper to elimination in 2 - 6 months

•Prednisone 40 - 80 mg single dose daily for 5 - 7 days; taper to elimination in 2 - 6 months

•Clofazimine in selected cases 300 mg daily for 6 weeks; then 100 - 200 mg daily for 6 - 12 months

•Clofazimine in selected cases 300 mg daily for 6 weeks; then 100 - 200 mg daily for 6 - 12 months

CONTINUE ANTIBACTERIAL TREATMENT AT FULL DOSESCONTINUE ANTIBACTERIAL TREATMENT AT FULL DOSES

Page 49: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

ENL TREATMENTENL TREATMENT

MildMild

•Symptomatic treatment•Symptomatic treatment

SevereSevere

•Thalidomide 400 mg daily tapered to 100 mg daily•Thalidomide 400 mg daily tapered to 100 mg daily

•Prednisone 40 - 80 mg daily•Prednisone 40 - 80 mg daily

•Clofazimine 100 - 300 mg daily•Clofazimine 100 - 300 mg daily

CONTINUE ANTIBACTERIAL TREATMENT AT FULL DOSES CONTINUE ANTIBACTERIAL TREATMENT AT FULL DOSES

Page 50: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

LENGTH OF STEROID TREATMENTLENGTH OF STEROID TREATMENT

No Evidence of NeuritisNo Evidence of Neuritis

Reaction with NeuritisReaction with Neuritis

• Treat according to symptoms

• ENL may require several years treatment

• Treat according to symptoms

• ENL may require several years treatment

• Minimum 3 months steroid treatment

• Longer periods for nerve pain or loss of nerve function

• Minimum 3 months steroid treatment

• Longer periods for nerve pain or loss of nerve function

Page 51: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

MONITORING PATIENTS WITH REACTIONSMONITORING PATIENTS WITH REACTIONS

• Primary concern is preventing permanent nerve damage

• Monitor regularly for sensory or motor changes in hands and feet or eye problems

• Note pain or tenderness of nerves

• Note edema of hands and feet

• Primary concern is preventing permanent nerve damage

• Monitor regularly for sensory or motor changes in hands and feet or eye problems

• Note pain or tenderness of nerves

• Note edema of hands and feet

Page 52: NATIONAL HANSEN’S DISEASE PROGRAM NATIONAL HANSEN’S DISEASE PROGRAM

NATIONAL HANSEN’S DISEASE

PROGRAMS

NATIONAL HANSEN’S DISEASE

PROGRAMS

Baton Rouge, Louisiana

Phone: 1-800-642-2477

Baton Rouge, Louisiana

Phone: 1-800-642-2477